TPG Completes Majority Investment in iNova Pharmaceuticals
October 31, 2022
TPG (through its Asia platform) completed a majority investment in iNova Pharmaceuticals, a multinational consumer health and pharmaceutical company, with existing investor Pacific Equity Partners re-investing as a minority co-investor. The deal will support iNova's regional expansion and growth strategy across Southeast and North Asia, and fund channel expansion, product-in-fill and technology investments.
- Buyers
- TPG (TPG Capital Asia), Pacific Equity Partners
- Targets
- iNova Pharmaceuticals
- Industry
- Pharmaceuticals
- Location
- Singapore
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
GIC and Temasek Acquire Significant Stake in Novotech as TPG Reinvests
March 31, 2025
Healthcare Services
Affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in Novotech, with existing investor TPG Asia reinvesting. The capital will support Novotech's global growth — including expansion in the US, Europe and APAC — and enable further organic investment and transformative M&A.
-
TPG to Acquire Nextech from Thomas H. Lee Partners
July 19, 2023
Healthcare Services
TPG (through its TPG Capital platform) has signed a definitive agreement to acquire Nextech, a provider of clinical and administrative healthcare technology and EMR software for specialty physician practices, from Thomas H. Lee Partners for $1.4 billion. The deal, expected to close in Q3 2023 subject to regulatory review, will allow TPG to expand its healthcare IT / SaaS portfolio and grow Nextech's platform and capabilities.
-
TPG Growth Makes Minority Investment in AnovoRx
January 12, 2022
Healthcare Services
TPG Growth has made a significant minority investment in AnovoRx Holdings, Inc. (Anovo), a specialty pharmacy and patient-support services provider that partners with biopharmaceutical manufacturers to deliver therapies to patients with rare and complex diseases. Financial terms were not disclosed; TPG said the investment will help Anovo expand its service offering, scale operations, and deepen relationships with manufacturer clients and patients.
-
Asia Healthcare Holdings (AHH) Acquires Nova IVI Fertility
May 2, 2019
Healthcare Services
Asia Healthcare Holdings (AHH), the TPG Growth‑backed single‑specialty healthcare platform, has signed definitive agreements to acquire Nova IVI Fertility. Nova operates 20 IVF centres across 15 Indian cities (performing more than 10,000 IVF treatments annually); the deal strengthens AHH's women & children's healthcare offering and scales its fertility capabilities across India.
-
TPG Capital and Vida Ventures Invest $225M in Asklepios BioPharmaceutical (AskBio)
April 11, 2019
Biotechnology
Asklepios BioPharmaceutical (AskBio) raised $235 million in new capital, with TPG Capital and Vida Ventures investing $225 million for a minority stake while AskBio’s founders and board co-invested $10 million. The funding will be used to accelerate clinical development and expand manufacturing capabilities, particularly for AskBio’s AAV gene therapy platform and pipeline.
-
TPG Growth Invests $30M in Solara Active Pharma
February 4, 2019
Pharmaceuticals
TPG Growth will invest $30 million in Solara Active Pharma to support the Indian API manufacturer's growth and capacity expansion into regulated markets. The minority growth equity investment is intended to help Solara scale manufacturing and R&D capabilities and strengthen its position with global generic customers in the US and Europe.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.